VACCINE AGAINST HIV INFECTION: A recent study found that the twice-yearly injection to protect women from the deadly AIDS, or HIV infection, was 100 percent successful in its trials. This means that HIV infection can now be prevented with the injection.
Scientists have said that with the help of this injection given twice a year, it will help protect women from HIV infection. Let us tell you that scientists have tested this injection on women and adolescent girls in South Africa and Uganda, with 100% success.
The drug is 100 percent effective in preventing HIV infection.
This injection has been tested on more than 5,000 women in South Africa and Uganda, with great success. In a report published in the New England Journal, the American company Gilead, which manufactures this drug, said that the name of the drug is. Lenacapavir (lenacapavir) and it proved to be a complete success in its third trial.
The company said that it is waiting for the results of the trials conducted on men before seeking approval to use this anti-HIV drug. Let us tell you that in the study conducted to measure the success of the drug, about five thousand HIV-negative women were studied. None of these women became victims of HIV after taking this drug.
This emerged during the 26-week research.
In this research that lasted for 26 weeks, no woman who took the dose of Lencapavir was infected, while in the other group, in which women were not given this drug, cases of infection were reported. Earlier, in another study, a group of women were given HIV prevention pills, but despite taking these pills, 2% of the women fell victim to HIV. Although this drug has not yet been approved by the United States Food and Drug Administration, it is believed that it will be soon and that this will help prevent HIV infection.
The price of medicines is also very low
The cost of the drug Lencapavir also remains very low. The company claims that the target has been set to bring down the price of the new drug to just forty dollars (Rs 3350) soon. At present, the cost of a dose of Lencapavir is around Rs 35 lakh, which is quite high for the general public.
It is said that if this drug is approved, women will be able to avoid HIV infection at a very low cost. This drug is also being tested on men and if this result is also positive, the world will be saved from the grip of AIDS and HIV.
Disclaimer: Some information given in the news is based on media reports. Before implementing any suggestion, you must consult the concerned expert.
also read this: Dengue fever is transmitted from person to person through these things, don’t make this mistake even by mistake
Discover the health tools below-
Calculate your body mass index (BMI)
